Skip to main content
. 2006 Apr 4;94(9):1293–1299. doi: 10.1038/sj.bjc.6603083

Table 2. Drug-related adverse events by NCI CTC grade.

  All (n=17)
Grade 3
 Leucopenia 1
 Neutropenia 3
 WBC decreased 1
   
Grade 2
 Leucopenia 2
 Thrombocytopenia 2
 Nausea 2
 WBC count decreased 1
 Skin disorders 6
 Hypotension 1
   
Grade 1
 Fever 4
 Thrombocytopenia 1
 Headache 1
 Skin disorders 7
 Folliculitis 1

DLT=dose-limiting toxicity; NCI CTC=National Cancer Institute Common Toxicity Criteria; WBC=white blood cell.

DLT was defined as grade 3 or 4 nonhaematologic toxicities (excluding headache, alopecia, nausea, vomiting, skin reactions, and fever above 40°C for less than 24 h); grade 4 nausea, vomiting, fever above 40°C sustained for more than 24 h; grade 3 or 4 neutropenia associated with complications (e.g. neutropenic fever); grade 4 thrombocytopenia, toxicity-related discontinuation of treatment for more than 1 week within the first two treatment cycles.

HHS Vulnerability Disclosure